Results 91 to 100 of about 3,379 (229)

Management of acute vertigo with betahistine

Indian Journal of Otolaryngology and Head and Neck Surgery, 2000
This open, prospective study was carried out in 29 outpatients of vertigo with Betahistine treatment at a dose of 16 mg three times daily far a maximum treatment period of 6 weeks or earlier until remission of vertigo attacks. The evaluations were carried out based on three parameters such as frequency, duration, and severity of vertigo attacks ...
R A, Bradoo, N K, Nerurkar, J B, Mhapankar, S F, Patil, D G, Kute   +4 more
openaire   +3 more sources

Comparative analysis of efficacy, safety, and cost-effectiveness of betahistine alone, caroverine alone, and caroverine plus ginkgo biloba in moderate tinnitus

Indian Journal of Pharmacology
BACKGROUND: Tinnitus or “phantom sound” continues to be a significant health problem without a uniformly accepted treatment. Numerous pharmaceutical options have been investigated, but satisfactory results are yet to be obtained.
Laxmipriya Nayak, Suhasini Dehury, S. Rautray, Lorika Sahu, D. Sahu   +4 more
semanticscholar   +1 more source

Mechanochemical Strategies Applied to the Late‐Stage Modifications of Pharmaceutically Active Compounds

Angewandte Chemie International Edition, Volume 64, Issue 41, October 6, 2025.
This review highlights mechanochemical strategies for the late‐stage modification of active pharmaceutical ingredients (APIs), providing a valuable resource for selecting substrates to evaluate the pharmaceutical potential of novel and existing (mechano)chemical protocols.
Johanna Templ, Lars Borchardt
wiley   +1 more source

Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results [PDF]

, 2018
Ménière's disease is a disorder of the inner ear that causes vertigo, tinnitus, fullness and hearing loss. Although several treatments are available, the success rate is reported to be around 70%, similar to placebo.
Augusto Pietro Casani, A. P. Casani, null null, G. Guidetti, R. Schoenhuber   +4 more
core   +1 more source

Tardive phenomenon presenting as isolated dysarthria: A rare entity mimicking stroke

Journal of Acute Disease, 2019
Distinguishing stroke mimics constitutes a considerable challenge for clinicians in emergency department. Here, we illustrate an extremely rare patient presenting with acute onset isolated dysarthria, who finally received diagnosis of tardive phenomenon ...
Halil Onder
doaj   +1 more source

Peripheral vertigo and appropriate use of Betahistine to improve outcomes

International Journal of Research in Medical Sciences
Vertigo, characterized by a spinning or whirling sensation, is a common condition with a prevalence of 4.9% in the general population. It is caused by dysfunction in the vestibular system and can be classified as peripheral or central.
Girish Raheja
semanticscholar   +1 more source

Quantitative Investigation of Nitrosamine Drug Substance‐Related Impurities (NDSRIs) Under Artificial Gastric Conditions by Liquid Chromatography–Tandem Mass Spectrometry and Structure–Activity Relationship Analysis

Drug Testing and Analysis, Volume 17, Issue 9, Page 1772-1784, September 2025.
The study provides information about the impact of physiological gastric conditions on the unbeneficial occurrence of nitrosamine drug substance–related impurities (NDSRIs). Both main factors for nitrosation in the form of acidic conditions and the presence of nitrite were adequately chosen for triggering the conversion of drug compounds into NDSRIs ...
Matthias Vogel, Sylvia E. Escher, Emanuel Weiler, Anke Londenberg, Uwe Deppenmeier, Rhys Whomsley   +5 more
wiley   +1 more source

Cochrane Analysis on Betahistine Omitted [PDF]

Deutsches Ärzteblatt international, 2013
Vertigo presents a trans-disciplinary challenge and it is therefore understandable that the neurologists establishing guidelines also include Meniere’s disease, a disorder of the inner ear. Unfortunately, Meniere’s disease causes not only vertigo in affected persons but also uncertainty among treating physicians, since even the etiology of the disease ...
openaire   +2 more sources

Gastroprotective Effects of Betahistine Against an Indomethacin-Induced Gastric Mucosal Ulcer in Rats: The Role of CINC-2α Gene

Medical Journal of The Islamic Republic of Iran
Background The role of histamine H3 receptors (H3Rs) in gastric protection and anti-inflammatory function is controversial. In this study, we investigated the gastroprotective effect of a histamine H3 receptor antagonist drug, betahistine, on cytokine ...
Shaghayegh Tarani, Gelareh Vahabzadeh, Hasan Fallah Huseini, Armin Khavandegar, B. Tavakoli-Far, Roshanak Jazayeri   +5 more
semanticscholar   +1 more source

Effects of olanzapine and/or betahistine treatment on body weight gain.

, 2014
A: Outline of the experimental design. B: The trend of three phases of drug administration on the accumulated body weight side-effect. Olanzapine (1 mg/kg, t.i.d.; n = 12), betahistine (9.6 mg/kg, t.i.d.; n = 12), co-treatment (O+B; n = 12) or control ...
Xu-Feng Huang (312380), Nagesh Pai (607404), Chao Deng (329151), Jiamei Lian (607403)   +3 more
core   +1 more source